You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for New Drug Application (NDA): 020589


✉ Email this page to a colleague

« Back to Dashboard


NDA 020589 describes CHILDREN'S ADVIL-FLAVORED, which is a drug marketed by Haleon Us Holdings and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the CHILDREN'S ADVIL-FLAVORED profile page.

The generic ingredient in CHILDREN'S ADVIL-FLAVORED is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
Summary for 020589
Tradename:CHILDREN'S ADVIL-FLAVORED
Applicant:Haleon Us Holdings
Ingredient:ibuprofen
Patents:1
Pharmacology for NDA: 020589
Mechanism of ActionCyclooxygenase Inhibitors
Suppliers and Packaging for NDA: 020589
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHILDREN'S ADVIL ibuprofen SUSPENSION;ORAL 020589 NDA Haleon US Holdings LLC 0573-0170 0573-0170-01 1 BOTTLE in 1 CARTON (0573-0170-01) / 30 mL in 1 BOTTLE
CHILDREN'S ADVIL ibuprofen SUSPENSION;ORAL 020589 NDA Haleon US Holdings LLC 0573-0170 0573-0170-30 1 BOTTLE in 1 CARTON (0573-0170-30) / 120 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SUSPENSION;ORALStrength100MG/5ML
Approval Date:Jun 27, 1996TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:SUSPENSION;ORALStrength100MG/5ML
Approval Date:Nov 7, 1997TE:RLD:No
Patent:10,238,640Patent Expiration:May 25, 2024Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 020589

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Haleon Us Holdings CHILDREN'S ADVIL ibuprofen SUSPENSION;ORAL 020589-001 Jun 27, 1996 4,788,220*PED ⤷  Subscribe
Haleon Us Holdings CHILDREN'S ADVIL-FLAVORED ibuprofen SUSPENSION;ORAL 020589-002 Nov 7, 1997 10,238,640 ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.